Cargando...
Access to innovative cancer medicines in a middle-income country - the case of Mexico
BACKGROUND: Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin American countries, Mexico has an essential cancer medicines list that includes innov...
Gardado en:
| Publicado en: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199792/ https://ncbi.nlm.nih.gov/pubmed/30386627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-018-0153-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|